Quick Takeaways
- Cynthia Smith has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,001,474.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Cynthia Smith
- Location
- New York, NY
- Summary
- The estimated net worth of Cynthia Smith is at least $1,001,474 dollars as of 13 Aug 2025. Cynthia Smith is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $525.1K. Cynthia Smith is the Director of Akebia Therapeutics, Inc. and owns shares of Akebia Therapeutics, Inc. (AKBA) stock worth about $421.6K. Cynthia Smith is the Director of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $54.8K.
- Signature
- /s/ William Cook, as attorney-in-fact for Cynthia Smith
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Cynthia Smith and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: AGIOS PHARMACEUTICALS, INC. ($525,080).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Cynthia Smith
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AGIO | AGIOS PHARMACEUTICALS, INC. | Director | $525,080 | 11 Aug 2025 | ||
| AKBA | Akebia Therapeutics, Inc. | Director | $421,644 | 10 Jun 2025 | ||
| SPRO | Spero Therapeutics, Inc. | Director | $54,750 | 12 Jun 2025 | ||
| DRNA | Dicerna Pharmaceuticals Inc | Director | 28 Dec 2021 | |||
| TARA | Protara Therapeutics, Inc. | Director | 12 Jun 2025 | |||
| TVRD | Tvardi Therapeutics, Inc. | Director | 17 Apr 2025 |
Insider Transactions Reported by Cynthia Smith:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.